Major Depressive Disorder Diagnosis: What to Expect

Getting an accurate diagnosis is the first step in effective depression treatment. Unlike many medical conditions, depression diagnosis is clinical rather than test-based: no blood test or brain scan can diagnose it. Instead, qualified mental health professionals conduct structured clinical interviews, apply formal diagnostic criteria (DSM-5 or ICD-11), use screening tools to support clinical judgment, perform medical workup to exclude organic causes, and work through differential diagnosis to distinguish MDD from related conditions. This guide covers the diagnostic process in detail: who can diagnose, what the assessment involves, what tests are appropriate, severity and specifier determination, India-specific context, common misdiagnosis patterns, and when to seek a second opinion.

Diagnosis overview

Major Depressive Disorder diagnosis follows a structured clinical process applied by qualified mental health professionals. The process is more standardised than many patients expect; clinicians use formal diagnostic criteria (DSM-5 in most clinical practice; ICD-10 or ICD-11 in some settings including Indian public hospitals) and structured interview frameworks to ensure consistency.

The core diagnostic question is whether the patient meets criteria for a major depressive episode: 5 or more of 9 specific symptoms present nearly every day for 2 weeks or longer, with at least one being depressed mood or loss of interest, causing significant distress or functional impairment, not better explained by another condition or substance. See our comprehensive MDD guide for detailed coverage of the diagnostic criteria.

The diagnostic process includes confirming criteria are met; excluding medical conditions and substance use that can produce similar symptoms; ruling out bipolar disorder, persistent depressive disorder, and other psychiatric conditions; grading severity (mild, moderate, severe); identifying specifiers that refine treatment; assessing suicide risk and functional impairment; planning appropriate treatment.

Despite the structured process, diagnosis remains a clinical judgment that integrates information across history, observation, and time. Two qualified clinicians may sometimes reach different conclusions on complex cases; this is part of why second opinions are reasonable for unclear presentations.

Who can diagnose MDD

For most uncomplicated cases, a GP or psychiatrist is appropriate first contact. Psychiatrist referral is particularly important when severity is moderate-to-severe, suicide risk is present, prior treatments have not worked, bipolar disorder is suspected, medical comorbidities complicate treatment, or medication is being considered.

The clinical interview

The clinical interview is the core of depression diagnosis. A typical 45-60 minute initial assessment follows a structured framework:

Some clinicians use structured tools (SCID-5, MINI) for research or complex cases. Most clinical practice uses semi-structured interviews tailored to the individual.

Screening tools

Screening tools support clinical assessment by quantifying symptoms and tracking change. They do not diagnose alone; clinical judgment integrates screening with interview and observation.

For routine practice, PHQ-9 is most commonly used and appropriate first-line screening. Specialised populations (postnatal, elderly) benefit from population-specific scales.

Medical workup

Standard medical workup excludes organic conditions that can produce depression-like symptoms or contribute to depression.

Recommended core workup:

• Thyroid function tests (TSH, T3, T4): hypothyroidism is a common reversible cause
• Vitamin B12 and folate: deficiency causes mood symptoms; common in vegetarian Indian patients
• Vitamin D: deficiency common in India even with abundant sunlight
• Full blood count: anaemia causes fatigue resembling depression
• Basic metabolic panel: kidney function, liver function, electrolytes
• HbA1c: if diabetes suspected or in older patients
• Calcium: if specific symptoms suggest hyperparathyroidism

Additional tests when specifically indicated: ECG if cardiac symptoms; brain imaging (CT or MRI) if neurological features, first episode after age 50, or treatment-resistant patterns; cortisol testing if Cushing syndrome suspected; ANA and autoimmune panel if relevant; HIV testing in appropriate contexts; syphilis screening when indicated; drug screen if substance use suspected.

The workup is targeted exclusion of common contributors rather than exhaustive screening. Treatment can begin alongside workup or after results return depending on severity. For severe depression with safety concerns, treatment usually starts before all results are available.

DSM-5 vs ICD-10/11 frameworks

Two main classification systems are used internationally for depression diagnosis.

DSM-5 (American Psychiatric Association, 2013). Used extensively in clinical research, USA, and increasingly globally including India. Requires 5 of 9 specific symptoms present nearly daily for 2 weeks or longer, including either depressed mood or anhedonia, with significant functional impairment.

ICD-10 (WHO, 1990). Still used in many clinical settings including Indian public hospitals. Depressive episode (F32) requires depressed mood, loss of interest, and reduced energy as core symptoms, plus additional symptoms. Categorises as mild (F32.0), moderate (F32.1), or severe (F32.2 without psychotic features, F32.3 with psychotic features). Recurrent depressive disorder is F33.

ICD-11 (WHO, 2022). Newest classification, gradually replacing ICD-10. Mostly aligned with DSM-5 criteria; depressive disorders organised under Mood Disorders chapter.

For patients, the practical implications are minimal: the same clinical picture is recognised across systems, treatment recommendations are similar, and the same medications and therapies are used.

Differential diagnosis

Differential diagnosis is one of the most important parts of MDD assessment. Several conditions present similarly but require different treatment.

Bipolar disorder differentiation is particularly important and easily missed. Specific questions about prior periods of unusually high energy, decreased need for sleep, racing thoughts, increased activity, or impulsive behaviour are essential. Family history of bipolar warrants careful assessment. Patients with bipolar depression often respond poorly or paradoxically to antidepressants alone.

Severity assessment

Once MDD diagnosis is established, severity grading guides treatment intensity.

Severity is assessed by symptom count, individual symptom intensity, and functional impact rather than only number. A patient with 5 mild symptoms producing minimal functional impact differs from a patient with 5 severe symptoms producing inability to work or self-care.

Specifier determination

DSM-5 includes specifiers describing additional features that refine treatment:

• With anxious distress: tension, restlessness; affects medication selection
• With mixed features: some manic or hypomanic symptoms; important to identify
• With melancholic features: severe anhedonia, lack of mood reactivity, early morning waking, psychomotor retardation
• With atypical features: mood improves with positive events, increased appetite, hypersomnia, rejection sensitivity
• With psychotic features: delusions or hallucinations; requires antipsychotic or ECT
• With peripartum onset: during pregnancy or within 4 weeks postpartum
• With seasonal pattern: less common in tropical India
• With catatonia: uncommon but serious; specific treatment

Suicide risk assessment

Suicide risk assessment is essential. Depression substantially increases suicide risk; assessing risk informs treatment intensity, monitoring frequency, and safety planning.

Components of suicide risk assessment: current thoughts (passive vs active), specific plans, access to means, stated intent, prior attempts (substantial risk factor), protective factors (reasons for living, social connections, family responsibilities), substance use (intoxication increases impulsive risk), recent stressors.

Risk assessment guides safety planning. For low-risk patients, standard treatment with monitoring is appropriate. For high-risk patients, more frequent contact, reducing access to means where safely possible, involving family, and sometimes hospitalisation may be indicated. Any positive suicidal ideation warrants serious attention.

If you have thoughts of self-harm, please contact a crisis helpline. Tele-MANAS (14416) in India; 988 in USA; Samaritans 116 123 in UK.

Diagnostic challenges

After diagnosis: next steps

India diagnostic context

Access pathways. Government hospitals (NIMHANS Bengaluru, AIIMS Delhi, state mental health institutes, District Mental Health Programme services) provide free or low-cost diagnosis. Costs typically registration fee only; medications often free in government settings. Waiting times can be substantial in major centres. Private psychiatric consultation in urban centres typically costs 800-3,000 INR for initial consultation, 500-2,000 INR for follow-up.

Tele-mental health. Tele-MANAS (14416, launched 2022) provides 24x7 confidential mental health support and can guide to local services. Increasingly important access pathway, particularly for rural patients. Private telepsychiatry expanded rapidly post-pandemic.

What to expect at consultation. Initial appointment usually 45-90 minutes at psychiatrists; shorter at busy government clinics. Detailed history-taking. Clinical interview structured around depression criteria. Often immediate symptom rating with PHQ-9 or similar. Medical workup ordered. Follow-up appointment scheduled. Medication or therapy planning discussed.

Cultural considerations. Stigma may make patients reluctant to disclose symptoms; consultation in family presence may limit disclosure of certain topics; cultural attribution to spiritual or character causes may affect treatment acceptance. Good clinicians address these; patients can ask for private time with clinician if family disclosure limits openness.

Mental Healthcare Act 2017. Strengthens rights to mental health treatment in India, including right to confidentiality, informed consent, advance directives, and access to community-based services.

Misdiagnosis patterns

Misdiagnosis happens in both directions.

Depression missed when present:

• Somatic presentation (especially in India) leading to repeated medical investigations
• Symptoms attributed to life circumstances ("just stress", "just exam pressure")
• Men presenting with irritability and substance use rather than classical sadness
• Elderly with symptoms attributed to ageing or dementia
• High-functioning patients maintaining external functioning
• Postnatal women whose symptoms are attributed to "normal" new parent fatigue
• Patients with chronic medical conditions where mood symptoms are attributed to the physical illness alone

Other conditions misdiagnosed as depression:

• Bipolar disorder treated as unipolar: particularly common; antidepressants alone can destabilise
• Hypothyroidism or vitamin deficiencies: medical conditions producing depression-like symptoms
• Anxiety disorders: primary anxiety with secondary depression
• Substance-induced mood disorders: alcohol, cannabis, prescription effects
• Medication side effects: some blood pressure medications, corticosteroids, hormonal medications
• Grief or adjustment disorder: not yet meeting full depression criteria
• Personality disorders with mood features: chronic patterns rather than discrete episode

When second opinion is appropriate

Seeking a second opinion is reasonable in several situations:

• Diagnosis is unclear after initial assessment
• You disagree with the diagnosis based on your own understanding of symptoms
• Treatment is not working after a reasonable trial (8-12 weeks of appropriate treatment)
• Multiple medications have been tried without benefit
• You suspect bipolar disorder may have been missed
• Complex comorbidities are involved
• Side effects from medication are problematic and alternatives are wanted
• You feel rushed or unheard in previous consultations

Second opinion does not mean rejecting the first clinician; it means seeking additional clinical perspective. Bring records from previous consultations including medications tried and any tests done.

A note from Dr. Boppana Sridhar

The first depression consultation is often the most important. Patients sometimes arrive nervous about what to expect, sometimes ashamed they need help, sometimes after years of trying to manage alone. What I want patients to know is that good diagnostic assessment is collaborative; the clinician's job is to listen carefully, ask the right questions, and integrate what you share with clinical knowledge to reach an accurate understanding. Be as open as you can; symptoms you might think are unimportant or unrelated often turn out to be diagnostically important. The screening for bipolar disorder is particularly important; patients sometimes do not recognise prior periods of elevated mood as relevant, but they substantially change treatment. Medical workup matters even when you feel sure the problem is psychological; identifying thyroid issues or vitamin deficiencies sometimes produces dramatic improvement with simple correction. If you feel rushed or unheard, this is information; consider whether this clinician is the right fit. For Indian patients specifically, I encourage you to be open about somatic symptoms; physical symptoms count and often help diagnostic clarity. The reaching out for assessment is itself the first step toward recovery.

Frequently asked questions

Related reading on 247healthcare.blog

• Mental Health and Primary Care: hub
• Depression and Mood Disorders: Pillar 2
• What is Major Depressive Disorder?
• Depression Symptoms in Adults
• Anxiety Disorders: Pillar 1
• CBT for Anxiety (and Depression)
• SSRIs and SNRIs Reference
• Anxiety and Sleep Problems

References

1. American Psychiatric Association. DSM-5 diagnostic criteria for Major Depressive Disorder.
2. NICE NG222. Depression in adults: treatment and management (2022).
3. WHO Depression Fact Sheet.
4. National Institute of Mental Health and Neuro Sciences (NIMHANS), Bengaluru.
5. MoHFW. National Mental Health Survey 2015-16.
6. Cochrane Library systematic reviews on depression diagnosis.
7. APA. Depression patient and family resources.
8. Mental Healthcare Act 2017, India.